Rabipur Rabies vaccine product alert for health professionals
Reports of rubber particles after reconstitution- recommendations to minimise the risk of particles
On 20 August 2024, Bavarian Nordic in agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) sent a communication out to customers regarding reports of rubber particles after reconstitution of the Rabipur rabies vaccine.
Recommendations have been provided to minimise the risk of particles. Information and advice is also available on the Valneva website for health professionals - see their direct healthcare professional communication letter here.
An analysis has revealed that these particles consisted of rubber, which was transferred from the rubber stopper of the vaccine vials during the reconstitution process (so called "coring").
Reconstituted Rabipur vaccine should be carefully visually inspected and must not be administered in case of visible particles. The letter contains recommendations on how to perform the reconstitution process, with the aim of minimising the risk of particles caused by "coring".
Health professionals with product quality complaints or clinical enquiries about the Rabipur vaccine should contact the manufacturers (see letter for contact details).
Suspected adverse drug reactions can be reported to the MHRA through the Yellow Card scheme and to Valneva.
Explore more
Celebrating Diwali abroad?
Reduce your risk of injury and illness while celebrating Diwali by following our travel health advice
Updated: 12 November 2026Help us to adapt a Travel Health Resource for UK Travellers
Take part in a study that aims to help UK travellers make informed choices about Japanese encephalitis (JE) vaccination
Updated: 26 October 2026Heading to the Youth Olympic Games in Senegal, West Africa, this autumn?
Make sure you are protected – get the right travel advice, vaccines and malarial tablets before you travel!
Updated: 12 November 2026Updated dengue 'green book' chapter published
The dengue chapter of the 'green book' (Immunisation against infectious disease) has been updated
Updated: 18 November 2026Mefloquine shortage
Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) continues
Updated: 09 September 2026
